<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04512859</url>
  </required_header>
  <id_info>
    <org_study_id>20200630</org_study_id>
    <nct_id>NCT04512859</nct_id>
  </id_info>
  <brief_title>Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage</brief_title>
  <official_title>Effect of Stellate Ganglion Block on Cerebral Vasospasm in Patients With Emergency Aneurysmal Subarachnoid Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate whether the stellate ganglion block is helpful in relieving cerebral vasospasm&#xD;
      during aneurysmal coil embolism surgery. The effect was assessed by Transcranial Doppler&#xD;
      (TCD).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of cerebral vasospasm</measure>
    <time_frame>Change from baseline at 5day,after subarachnoid hemorrhage</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Subarachnoid Hemorrhage, Aneurysmal</condition>
  <condition>Cerebral Vasospasm</condition>
  <arm_group>
    <arm_group_label>Stellate Ganglion Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental patients will receive a stellate ganglion block with 0.25% ropivacaine 10mL on the same side of vasospasm at the level of the sixth cervical vertebrae (C6) before surgery.&#xD;
Patients were then assessed using transcranial Doppler</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Stellate Ganglion Block</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients will receive a stellate ganglion block with 0.9% saline 10mL on the same side of vasospasm at the level of the sixth cervical vertebrae (C6) before surgery.&#xD;
Patients were then assessed using transcranial Doppler</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stellate Ganglion Block</intervention_name>
    <description>Stellate ganglion block under ultra-guide will be administered using 0.25% ropivacaine 10mL</description>
    <arm_group_label>Stellate Ganglion Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Stellate ganglion block under ultra-guide will be administered using 0.9% saline 10mL</description>
    <arm_group_label>No Stellate Ganglion Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1.Emergency patients with subarachnoid hemorrhage caused by ruptured aneurysm, aged&#xD;
             18-65 years; 2. ASA : II-IV grade, Hunt-Hess : I-III grade 3. For the first case, the&#xD;
             operation time is within 24 hours. 4.After signing informed consent, underwent&#xD;
             interventional intravascular embolization&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. Patients with severe bleeding disorders; 2. Patients with trauma and local&#xD;
             infection risk in the nerve block area; 3. Patients with previous aneurysm surgery and&#xD;
             unruptured aneurysm; 4. Aneurysm located in middle cerebral artery; 5. Patients with&#xD;
             unconsciousness cannot cooperate with the block operation; 6. Those with a history of&#xD;
             mental illness and epilepsy; 7. Those who have a history of severe cardiovascular and&#xD;
             cerebrovascular diseases and severe organ diseases;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2020</study_first_posted>
  <last_update_submitted>September 6, 2020</last_update_submitted>
  <last_update_submitted_qc>September 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Yuming Peng</investigator_full_name>
    <investigator_title>Vice Professor</investigator_title>
  </responsible_party>
  <keyword>Stellate Ganglion Block</keyword>
  <keyword>Subarachnoid Hemorrhage</keyword>
  <keyword>Cerebral Vasospasm</keyword>
  <keyword>Transcranial Doppler Ultrasonography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ganglion Cysts</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Vasospasm, Intracranial</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

